Related Experiment Video
Updated: Jun 20, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Cardiotoxicity after low-dose chloroquine antimalarial therapy
Gabriele Fragasso1, Francesca Sanvito, Francesca Baratto
1Clinical Cardiology, Heart Failure Clinic, Istituto Scientifico San Raffaele, Milan, Italy. gabriele.fragasso@hsr.it
Low-dose chloroquine prophylaxis for malaria can cause heart failure. Early recognition and drug withdrawal are crucial for reversible cardiac toxicity and preventing severe outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Infectious Diseases
Background:
- Antimalarial toxicity is typically linked to high-dose, long-term use for nonmalarial conditions.
- Chloroquine is a widely used antimalarial drug with a known safety profile.
Observation:
- A patient with recurrent malaria developed heart failure and biventricular cardiac dysfunction.
- The patient was receiving prophylactic low-dose chloroquine treatment.
Findings:
- Endomyocardial biopsy results were indicative of chloroquine-induced cardiotoxicity.
- Cardiac function improved significantly after discontinuing chloroquine.
Implications:
- This case highlights the potential for cardiotoxicity even with low-dose chloroquine in malaria patients.
- Early detection of toxicity signs is vital to prevent irreversible cardiac damage and life-threatening complications.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Drug Toxicity: Dose-Dependent Reactions
Cardiomyopathy V: Interprofessional Care
Drug Toxicity: Risk factors
Drug toxicity: Idiosyncratic Reactions
Cardiomyopathy II: Dilated Cardiomyopathy

